New inhaled treatment could reduce need for breathing tubes in premature babies
Disease control
Recruiting now
This study tests a new inhaled medication (APC-0101) in 520 premature babies born 26-33 weeks who have breathing problems. The medication is given through a special device while the baby is on non-invasive breathing support. The goal is to see if it reduces the need for a breathi…
Phase: PHASE3 • Sponsor: Aerogen Pharma Limited • Aim: Disease control
Last updated May 26, 2026 10:58 UTC